Esophageal Cancer Virus Therapy: Telomelysin Goes on Sale in Japan at $58,000
Japan has begun selling Telomelysin, a rewired cold virus that multiplies only inside cancer cells and goes into esophageal tumors by endoscope. Three doses list at 9.3 million yen; the trial behind it had 37 patients.